Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients

Neal Navani*, James M. Brown, Matthew Nankivell, Ian Woolhouse, Richard N. Harrison, Vandana Jeebun, Mohammed Munavvar, Benjamin J. Ng, Doris M. Rassl, Mary Falzon, Gabrijela Kocjan, Robert C. Rintoul, Andrew G. Nicholson, Sam M. Janes

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

192 Citations (Scopus)

Abstract

Rationale: The current management of advanced non-small cell lung cancer (NSCLC) requires differentiation between squamous and nonsquamous subtypes as well as epidermal growth factor receptor (EGFR) mutation status. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasingly used for the diagnosis and staging of lung cancer. However, it is unclear whether cytology specimens obtained with EBUS-TBNA are suitable for the subclassification and genotyping of NSCLC. Objectives: To determine whether cytology specimens obtained from EBUS-TBNA in routine practice are suitable for phenotyping and genotyping of NSCLC. Methods: Cytological diagnoses from EBUS-TBNA were recorded from 774 patients with known or suspected lung cancer across five centers in the United Kingdom between 2009 and 2011. Measurements and Main Results: The proportion of patients with a final diagnosis by EBUS-TBNA in whom subtype was classified was 77% (95% confidence interval [CI], 73-80). The rate of NSCLC not otherwise specified (NSCLC-NOS) was significantly reduced in patients who underwent immunohistochemistry (adjusted odds ratio, 0.50; 95% CI, 0.28-0.82; P = 0.016). EGFR mutation analysis was possible in 107 (90%) of the 119 patients in whom mutation analysis was requested. The sensitivity, negative predictive value, and diagnostic accuracy of EBUS-TBNA in patients with NSCLC were 88% (95% CI, 86-91), 72% (95% CI, 66-77), and 91%(95% CI, 89-93), respectively. Conclusions: This large, multicenter, pragmatic study demonstrates that cytology samples obtained from EBUS-TBNA in routine practice are suitable for subtyping of NSCLC and EGFR mutation analysis and that theuse of immunohistochemistry reduces therate of NSCLC-NOS.

Original languageEnglish
Pages (from-to)1316-1322
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume185
Issue number12
DOIs
Publication statusPublished - 15 Jun 2012
Externally publishedYes

Keywords

  • Adenocarcinoma
  • EGFR mutation
  • Endobronchial ultrasound
  • Non-small cell lung cancer
  • NSCLC-NOS

Fingerprint Dive into the research topics of 'Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients'. Together they form a unique fingerprint.

Cite this